Influence of the lactose grade within dry powder formulations of fluticasone propionate and terbutaline sulphate

被引:17
|
作者
Le, V. N. P. [1 ]
Bierend, H. [2 ]
Robins, E. [3 ]
Steckel, H. [2 ]
Flament, M. P. [1 ]
机构
[1] Univ Lille Nord France, Coll Pharm, INSERM 1008, F-59006 Lille, France
[2] Univ Kiel, Inst Pharmaceut, D-24118 Kiel, Germany
[3] APTAR Pharma, F-27100 Le Vaudreuil, France
关键词
Dry powder inhalation; Lactose; Physicochemical properties; Adhesion; Aerodynamic behaviour; Inverse gas chromatography; INVERSE GAS-CHROMATOGRAPHY; SALBUTAMOL SULFATE; INHALATION FORMULATIONS; INTERACTIVE MIXTURES; SURFACE-ENERGY; IN-VITRO; PERFORMANCE; CARRIER; DISPERSION; FUNCTIONALITY;
D O I
10.1016/j.ijpharm.2011.10.030
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dry powder formulations are often composed of fine drug particles and coarser carrier particles, typically alpha-lactose monohydrate. However, the performance of a powder formulation may be highly dependent on the lactose quality and source. This study investigated the characteristics of lactose that influence the drug-to-carrier interaction and the performance of lactose-based dry powder inhaler formulations. The selected lactoses differed in the preparation processes and the content of fine lactose particles. Efficiency testing was done using fluticasone propionate and terbutaline sulphate as model drugs. Inverse gas chromatography was used to determine the surface heterogeneity distribution of different energy sites of the lactose and to understand the mechanism by which the fine carrier particles can improve the performance of dry powder inhalers. To assess the adhesion of respirable-sized drug to carrier particles, a simple method was developed based on aspiration and considering the whole blend as it is used in dry powder inhalers. When the percentage of fine lactose is high, a lower quantity of drug adheres to the lactose and/or the adhesion force is also lower. This was confirmed by the aerosolization assays done in the TSI (twin stage impinger). A correlation was observed between adhesion characteristics and inertial impaction. For both drugs, the fine particle fractions were highest in blends that present a greater proportion of lactose fine particles. A fairly good correlation between the fine particle fractions of both drugs and the peak max value and the AUC (area under curve) were found by inverse gas chromatography. With higher fine particle fraction values, which correspond to higher content of fines, the peak maxima determined by inverse gas chromatography were shifted to higher adsorption potentials, which supports the agglomeration hypothesis. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:75 / 82
页数:8
相关论文
共 50 条
  • [1] Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations
    Le, V. N. P.
    Robins, E.
    Flament, M. P.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2012, 80 (03) : 596 - 603
  • [2] Dry Powder Formulations for Inhalation of Fluticasone Propionate and Salmeterol Xinafoate Microcrystals
    Murnane, Darragh
    Martin, Gary P.
    Marriott, Christopher
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 98 (02) : 503 - 515
  • [3] Adrenal suppression with dry powder formulations of fluticasone propionate and mometasone furoate
    Fardon, TC
    Lee, DKC
    Haggart, K
    McFarlane, LC
    Lipworth, BJ
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (09) : 960 - 966
  • [4] Dry powder inhalers: Mechanistic evaluation of lactose formulations containing salbutamol sulphate
    Kaialy, Waseem
    Ticehurst, Martyn
    Nokhodchi, Ali
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 423 (02) : 184 - 194
  • [5] Can Pharmacokinetic Studies Assess the Pulmonary Fate of Dry Powder Inhaler Formulations of Fluticasone Propionate?
    Hochhaus, Gunther
    Chen, Mong-Jen
    Kurumaddali, Abhinav
    Schilling, Uta
    Jiao, Yuanyuan
    Drescher, Stefanie K.
    Amini, Elham
    Kandala, Bhargava
    Tabulov, Christine
    Shao, Jie
    Seay, Brandon
    Abu-Hasan, Mutasim N.
    Baumstein, Sandra M.
    Winner, Lawrence
    Shur, Jagdeep
    Price, Robert
    Hindle, Michael
    Wei, Xiangyin
    Carrasco, Cynthia
    Sandell, Dennis
    Oguntimein, Oluwamurewa
    Kinjo, Minori
    Delvadia, Renishkumar
    Saluja, Bhawana
    Lee, Sau L.
    Conti, Denise S.
    Bulitta, Jurgen B.
    AAPS JOURNAL, 2021, 23 (03):
  • [6] Can Pharmacokinetic Studies Assess the Pulmonary Fate of Dry Powder Inhaler Formulations of Fluticasone Propionate?
    Günther Hochhaus
    Mong-Jen Chen
    Abhinav Kurumaddali
    Uta Schilling
    Yuanyuan Jiao
    Stefanie K. Drescher
    Elham Amini
    Simon M. Berger
    Bhargava Kandala
    Christine Tabulov
    Jie Shao
    Brandon Seay
    Mutasim N. Abu-Hasan
    Sandra M. Baumstein
    Lawrence Winner
    Jagdeep Shur
    Robert Price
    Michael Hindle
    Xiangyin Wei
    Cynthia Carrasco
    Dennis Sandell
    Oluwamurewa Oguntimein
    Minori Kinjo
    Renishkumar Delvadia
    Bhawana Saluja
    Sau L. Lee
    Denise S. Conti
    Jürgen B. Bulitta
    The AAPS Journal, 23
  • [7] Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler
    Singh, Deepak J.
    Jain, Rajesh R.
    Soni, P. S.
    Abdul, Samad
    Darshana, Hegde
    Gaikwad, Rajiv V.
    Menon, Mala D.
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2015, 28 (04) : 254 - 267
  • [8] Correction to: Can Pharmacokinetic Studies Assess the Pulmonary Fate of Dry Powder Inhaler Formulations of Fluticasone Propionate?
    Günther Hochhaus
    Mong-Jen Chen
    Abhinav Kurumaddali
    Uta Schilling
    Yuanyuan Jiao
    Stefanie K. Drescher
    Elham Amini
    Simon M. Berger
    Bhargava Kandala
    Christine Tabulov
    Jie Shao
    Brandon Seay
    Mutasim N. Abu-Hasan
    Sandra M. Baumstein
    Lawrence Winner
    Jagdeep Shur
    Robert Price
    Michael Hindle
    Xiangyin Wei
    Cynthia Carrasco
    Dennis Sandell
    Oluwamurewa Oguntimein
    Minori Kinjo
    Renishkumar Delvadia
    Bhawana Saluja
    Sau L. Lee
    Denise S. Conti
    Jürgen B. Bulitta
    The AAPS Journal, 24
  • [9] FLUTICASONE PROPIONATE AND FLUTICASONE PROPIONATE/SALMETEROL MULTIDOSE DRY POWDER INHALER PHARMACOKINETICS IN PATIENTS WITH PERSISTENT ASTHMA
    Ratner, P.
    Yiu, G.
    Nugent, C.
    Song, S.
    Caracta, C.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S65 - S66
  • [10] FLUTICASONE PROPIONATE AND FLUTICASONE PROPIONATE/SALMETEROL DELIVERED VIA MULTIDOSE DRY POWDER INHALERS FOR PERSISTENT ASTHMA
    Raphael, G.
    Yiu, G.
    Sakov, A.
    Liu, S.
    Caracta, C.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S63 - S63